Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-17

FDA Approved: VECTICAL — Supplemental Application (Galderma Laboratories, L.P.)

View source ↗

Summary

The FDA approved a supplemental application for VECTICAL (calcitriol) from Galderma Laboratories to expand its labeling for use in psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VECTICAL (Calcitriol)

Snippet

SUPPL AP for VECTICAL (CALCITRIOL)